When the stirring's done may I lick the spoon
Branch Chief - Cell Therapy Branch 2; Office of Therapeutic Products; US Food & Drug Administration
Experienced reviewer for cell and gene therapy products throughout all stages of the product development lifecycle (pre-IND, IND, and marketing applications/BLAs) with more than a decade of experience in medical-related research focused on immunology and development of cellular therapies for treatment of cancer and immune-mediated disorders.
- Will BLA or IND applications that were under review in OTAT prior to the reorganization be affected? Will the processing of these applications take longer because of these changes?
- OTP’s goal is to maintain review teams for existing applications throughout the reorganization. However, the responsible offices and divisions, as well as the signatory authority responsible for existing applications, may change – this will be determined by several factors, including how far along the review of the application is at the time of the reorganization.
- OTP is committed to meeting all statutory commitments.
I am trying to find out what the Cell Therapy Branches do?
Klinker heads up Branch 2- what does Branch 2 do?
Does it process BLA's ?????????
I will keep looking- but have errands to run- go ahead, make my day.....................happy sleuthing
Reg
When the stirring's done may I lick the spoonBranch Chief - Cell...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.28 |
Change
-0.030(2.29%) |
Mkt cap ! $1.461B | |||
| Open | High | Low | Value | Volume |
| $1.32 | $1.35 | $1.28 | $1.677M | 1.289M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 44452 | $1.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.29 | 23596 | 1 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |